Human gastrointestinal microbiome modulating composition and methods of use
AssigneeMicroBiome Therapeutics, LLC
InventorsMark L. Heiman, Dean P. Stull, Justin W. Peno
Life of this patent
Estimating the term…
Loading patent…
AssigneeMicroBiome Therapeutics, LLC
InventorsMark L. Heiman, Dean P. Stull, Justin W. Peno
Estimating the term…
A formulation to increase the ratio of gastrointestinal microbiota in phylum Bacteroidetes to microbiota of Firmicutes phylum preferably includes about 20-60 mg/kg of body weight of fermentable fiber, about 10-30 mg/kg of body weight of beta glucan and about 20-60 mg/kg of body weight of blueberry extracts or any fruit or berry ingredient preparation containing similar phenolics. This formulation is preferably used to control body weight, body composition, and blood glucose regulation, preferably in humans, and is preferably administered orally, preferably twice per day.
A human gastrointestinal microbiome modulating composition for improving blood glucose regulation in a human in need thereof which has fewer than 200 usable Calories per therapeutic dose, comprising:
Dependencies are inferred from the claim text.